Figure 1. Frequency of Events and Death Among Randomized Patients in the Dual Antiplatelet Therapy (DAPT) Study.

Shown are cumulative rates of cardiovascular and bleeding events and subsequent risk of death. The number of each event represents the number of patients experiencing the event. Multiple types of events could be experienced by the same patient. For patients with more than one of the same type of event, only the earliest event contributed to the analysis. Other cardiovascular deaths were defined as any cardiovascular death not preceded by a myocardial infarction (MI), stent thrombosis (ST), or ischemic stroke. These events primarily consisted of sudden cardiac deaths (n = 40), heart failure–related deaths (n = 9), and fatal ventricular arrhythmias (n = 4). GUSTO indicates Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries.